References

Abbasi, M., G.M. Chertow and Y.N. Hall, 2010. Clinical evidence, kidneys disorder, end stage renal disease. Clinical Evidence.

Ali, A., R. Vasudevan, P. Ismail, C.L.T. Seong and S. Chakravarthi, 2011. Analysis of insertion deletion polymorphisms of the angiotensin converting enzyme gene in Malaysian end-stage renal disease patients. J. Renin. Angiotensin. Aldosterone. Syst., 1: 224-230.

Annis, M.M. and J.B. Nancy, 2007. Aldosterone and end-organ damage. Clin. Sci., 113: 267-278.

Bowden, D.W., 2003. Genetics of kidney disease. Kidney. Int., 63: 8-12.

Buraczynska, M., P. Ksiazek, A. Drop, W. Zaluska, D. Spasiewicz and A. Ksiazek, 2006. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol. Dial. Transplant., 21: 979-983.
CrossRef  |  

Casiglia, E., V. Tikhonoff, A. Mazza, A. Rynkiewicz and J. Limon et al., 2005. C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: A population-based study. J. Hypertens, 23: 1991-1996.

Diepeveen, S.H., J.F. Wetzels, H.J. Bilo, L.J. van Tits and A.F. Stalenhoef, 2008. Cholesterol in end-stage renal disease: The good, the bad or the ugly. Neth. J. Med., 66: 53-61.
PubMed  |  

Fabris, B., M. Bortoletto, R. Candido, F. Barbone and M.R. Cattin, 2005. Genetic polymorphisms of the rennin-angiotensin aldosterone system and renal insufficiency in essential hypertension. J. Hypertens, 23: 309-316.
PubMed  |  

Gu, D., D. Ge, J. He, B. Li, J. Chen and D. Liu, 2004. Haplotypic analyses of the aldosterone synthase gene cyp11b2 associated with stage-2 hypertension in Northern Han Chinese. Clin. Genet., 66: 409-416.
PubMed  |  

Gumprecht, J., M.J. Zychma, W. Grzeszczak and S.E. Zukowska, 2000. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure. Kidney. Int., 58: 513-519.
Direct Link  |  

Hautanen, A., L. Lankinen, M. Kupari, O.A Janne and H. Adlercreutz et al., 1988. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J. Intern. Med., 244: 11-18.
PubMed  |  

Kuhnlea, U., L. Sabina and P.J. Fullerc, 2004. Endocrine disorders of sodium regulation. Horm. Res., 61: 68-83.

Lee, J.E., S.Y. Bae, J.Y. Kim and H.J. Pyo, 2009. Aldosterone synthase gene (CYP11B2) polymorphism in korean end-stage renal disease patients on hemodialysis. Electrolytes Blood Press, 7: 67-72.

Letchuman, G.R., W.M.W. Nazaimoon, W.B.W. Mohamad, L.R. Chandran and G.H. Tee et al., 2010. Prevalence of diabetes in the malaysian national health morbidity survey III 2006. Med. J. Malaysia, 65: 173-179.
Direct Link  |  

Lovati, E., A. Richard, B.M. Frey, F.J. Frey and P. Ferrari, 2001. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int., 60: 46-54.
CrossRef  |  PubMed  |  

Munshi, A., V. Sharma, S. Kaul, K. Rajeshwar and M.S. Babu et al., 2010. Association of the 344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. J. Neurol. Sci., 296: 34-38.

Orth, S.R., 2002. Smoking and the kidney. J. Am. Soc. Nephrol., 13: 1663-1672.

Pan, X.Q., Y.H. Zhang, Y.Y. Liu and W.J. Tong, 2010. Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population. Eur. J. Epidemiol., 25: 813-821.
PubMed  |  

Prasad, P., A.K. Tiwari, K.M.P. Kumar, A.C. Ammini and G. Arvind et al., 2006. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. Biol. Med. Genet., 7: 42-42.

Shlush, L.I., S. Bercovici, W.G. Wasser, G. Yudkovsky, A. Templeton, D. Geiger and K. Skorecki, 2010. Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers. Med, Genomics, 3: 47-47.

Tang, W., H. Wu, X. Zhou, B. Cheng and Y. Dong et al., 2006. Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin. Chim. Acta, 364: 222-225.
PubMed  |  

Tripathi, G., R.K. Sharma, V.P. Baburaj, S.N. Sankhwar, T. Jafar and S. Agrawal, 2008. Genetic risk factors for renal failure among North Indian ESRD patients. Clin. Biochem., 41: 525-531.
PubMed  |  

Vasudevan, R., P. Ismail, J. Stanslas, N. Shamsudin and A. Ali, 2008. Association of insertion/deletion polymorphism of α-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian subjects. Int. J. Biol. Sci., 4: 362-367.

White, P.C. and L. Slutsker, 1995. Haplotype analysis of CYP11B2. Endocr. Res., 21: 437-442.

Wong, C., P. Kanetsky and D. Raj, 2008. Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr. Nephrol., 23: 1037-1051.
CrossRef  |  

Worobey, C.C., N.D.L. Fisher, D. Cox, J.P. Forman and G.C. Curhan, 2009. Genetic polymorphisms and the risk of accelerated renal function decline in women. Genet. Renal. Funct., 4: 4787-4787.